DUBLIN--(BUSINESS WIRE)--The "Engineered T Cells Market by Type, Application and End User - Global Opportunity Analysis and Industry Forecast, 2017-2023" report has been added to ResearchAndMarkets.com's offering.
The global engineered T cells market was valued at $145.97 million in 2016, and is estimated to reach at $2,124.02 million by 2023, registering a CAGR of 46.5% from 2017 to 2023.
T cell is a type of white blood cell, and plays an important role in cell-medicated immunity. Engineered T cells are genetically modified T cells, specifically altered for therapeutic actions against autoimmune diseases and various types of cancers. The engineered T cells are delivered into patient's body to reduce toxicity levels and restrict antigen escape for elimination of cancerous cells.
Increase in of incidence of various types of cancers and autoimmune diseases is projected to drive the growth of the engineered T cells market. In addition, advantages offered by engineered T cells therapies over traditional cancer treatments such as chemotherapy, high technological advancements, and increase access to medical insurance are expected to boost the market growth.
The engineered T cells market is segmented based on type, application, end user, and geography. On the basis of type, the market is categorized into chimeric antigen receptor (CAR) modified T cells, tumor infiltrating lymphocytes (TIL), and T cells receptor (TCR) modified T cells. By application, it is classified into lung cancer, breast cancer, colorectal cancer, melanoma, leukemia, and other applications. Depending on end user, it is fragmented into hospitals, cancer research centers, and clinics.
- Autolus Limited
- Bellicum Pharmaceuticals, Inc.
- Cell Medica
- Elli Lilly and Company
- Gilead Sciences, Inc.
- Juno Therapeutics
- Novartis AG
- Oxford Biomedica
- Pfizer Inc.
- Precision Bioscience
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Executive Summary
Chapter 3 Market Overview
Chapter 4 Engineered T Cells Market, By Type
Chapter 5 Engineered T Cells Market, By Application
Chapter 6 Engineered T Cells Market, By End User
Chapter 7 Engineered T Cells Market, By Region
Chapter 8 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/3fcjvs/global_engineered?w=4